Document Detail


Do we need individualised prescribing quality assessment? The case of diabetes treatment.
MedLine Citation:
PMID:  21744186     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Prescribing quality assessment is increasingly used in improvement programs and pay-for-performance policies. Within the area of diabetes many quality indicators have been developed. Some measure prescribing on a general level, e.g. calculating percentages of patients prescribed any statins. Others are very specific, e.g. percentages of patients with an elevated LDL-cholesterol in whom lipid-lowering treatment is started unless contraindicated or return to control within 3 months. Although the latter seems more precise, we question how far one should go in developing such indicators. Using the example of diabetes treatment, we highlight the need, opportunities, and feasibility of assessing prescribing quality in the context of individualised treatment. We conclude that it is not realistic to develop indicators that take all possible aspects of therapy non-respons, intolerance and patient preferences into account. We do recommend further development of indicators that better address subpopulations in need of adjusted treatment, such as elderly or patients with comorbidity.
Authors:
Petra Denig; Flora Haaijer-Ruskamp
Related Documents :
1590766 - Increases in intestinal glucose absorption and hepatic glucose uptake elicited by lumin...
11451366 - The role of glucose in supporting motility and capacitation in human spermatozoa.
10099606 - Generalized linearization of kinetics of glucose isomerization to fructose by immobiliz...
3141296 - Glucose, fructose, and xylitol in postoperative hypocaloric parenteral nutrition.
2475546 - A method for localizing the early products of nonenzymatic glycosylation in fixed tissue.
2413686 - Normalization of monocyte chemotaxis precedes clinical resolution of psoriasis treated ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of clinical pharmacy     Volume:  33     ISSN:  2210-7711     ISO Abbreviation:  Int J Clin Pharm     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-07-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101554912     Medline TA:  Int J Clin Pharm     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  145-9     Citation Subset:  IM    
Affiliation:
Department of Clinical Pharmacology, University of Groningen, UMCG, PO Box 196, 9700 AD, Groningen, Netherland, p.denig@med.umcg.nl.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hybrid gel composed of native heart matrix and collagen induces cardiac differentiation of human emb...
Next Document:  Efficacy and safety of dexmedetomidine versus morphine in post-operative cardiac surgery patients.